The impact of nurse turnover in 2022, what you need to know about CMS' proposed IPPS rule, and more.

Are we entering a new era of weight-loss medication? (Monday, April 10)

Demand for semaglutide, a popular weight-loss treatment, has surged in recent months, and it will likely soon face stiff competition as a new "King Kong" treatment — as well as several other drugs in the weight-loss market pipeline — gain ground.

Charted: The impact of nurse turnover in 2022 (Tuesday, April 11)

A new report from NSI Nursing Solutions found that RN turnover rates decreased by nearly 5% in 2022. Here's what the trend means for you — and what you still must do to stabilize your workforce, according to Advisory Board's Carol Boston-Fleischhauer, Donald Malott, and Jennifer Bierhoff.

What you need to know about CMS' proposed IPPS rule (Wednesday, April 12)

CMS last week released its proposed inpatient prospective payment system rule for fiscal year 2024, which would increase Medicare payments to hospitals by a net 2.8% compared to 2023. But many hospital groups say the increase isn't enough to offset inflation, labor, and other costs.

How recent court rulings could turn FDA's drug-approval process 'upside down' (Thursday, April 13)

Following recent rulings on whether FDA's approval of the abortion pill mifepristone is valid, industry stakeholders have voiced concern that the decision could undermine FDA's authority and turn the drug-approval process "upside down." While it is still unclear exactly how the legal battle surrounding mifepristone will unfold, Advisory Board's Fanta Cherif and Amanda Okaka highlight three significant life sciences implications.

How ice cream can impact your health (hint: it might be good for you) (Friday, April 14)

Ice cream has typically been considered an indulgent dessert, but multiple studies have found that ice cream may be associated with various health benefits, David Merritt Johns reports for The Atlantic.